Table 2b.

Results of multinomial logistic regression, part 2

Odds of agreeing or disagreeing that the benefits of PSA screening in average-risk men outweigh the risks, compared to a neutral response

	In average-risk men (i.e., no risk factors for prostate cancer) the benefits of prostate cancer screening outweigh the risks
	Disagree			Agree
	OR	95% CI		OR	95% CI
		Lower	Upper		Lower	Upper
Read guidelines (yes vs. no)	1.88	1.25	2.85	1.36	0.85	2.18
Academic appointment (yes vs. no)	1.51	1.08	2.13	0.83	0.56	1.24
Catchment area
Small	Ref			Ref
Medium	0.93	0.57	1.52	0.87	0.48	1.56
Large	0.87	0.58	1.30	0.94	0.58	1.52
Gender (female vs. male)	1.37	0.97	1.94	0.84	0.55	1.29
Years in practice
<5	Ref			Ref
5–10	0.69	0.44	1.09	1.54	0.86	2.77
10–20	0.59	0.36	0.95	2.00	1.12	3.58
>20	1.04	0.65	1.65	3.55	2.03	6.19
Province
Maritime + territories	Ref			Ref
BC	0.99	0.50	1.96	0.93	0.44	1.96
Prairies	1.06	0.54	2.08	0.69	0.32	1.45
Central	1.40	0.73	2.70	0.55	0.26	1.14

Bold values are statistically significant (p<0.05). CI: confidence interval; OR: odds ratio; PSA: prostate-specific antigen; Ref: reference.